• Business Bay DHA-I Islamabad
MENU

Buy AMMOIDIN 0.75% Ointment 30g Online At Best Price In Pakistan

Dosage

Missed Dose

Since this medicine is usually administered in the clinical/hospital setting, the likelihood of a missed dose is very low. However, since this medicine is usually given in multiple cycles, if you miss a scheduled dose of this medicine, call your doctor immediately for further instructions.

Overdose

Since this medicine is usually administered in the clinical/hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Griseofulvin   (moderate)

Tizanidine   (severe)

Prochlorperazine   (moderate)

Prescribes

Vitiligo

This medicine is used for the treatment of vitiligo, a skin condition characterized by loss of skin color in patches.

Psoriasis

This medicine is used for the treatment of psoriasis, a skin disease characterized by excessive scaling, dryness, rashes, and itching of the skin.

Cutaneous T-cell Lymphoma

This medicine is used to treat cutaneous T-cell lymphoma, a rare type of cancer that begins in the white blood cells and attacks the skin.

Side Effects

Redness of skin  

Itching  

Nausea  

Trouble sleeping  

Darkening of skin  

Low blood pressure  

Blistering and peeling of skin  

Swelling in the arms or legs  

Warnings

Driving and operating machinery
Aging of skin and skin burning
Carcinogenicity
Use in children
Pregnancy
Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to AMMOIDIN 0.75% Ointment 30g , any psoralen compounds, or any other inactive ingredients present along with it.

Aphakia

This medicine is not recommended for use in patients suffering from aphakia due to the increased risk of worsening of the patient's condition.

Melanoma

This medicine is not recommended for use in patients with a history of melanoma due to the increased risk of worsening of the patient's condition.

Squamous Cell Carcinoma

This medicine is not recommended for use in patients with invasive squamous cell carcinomas due to the increased risk of worsening of the patient's condition.